vs

Side-by-side financial comparison of BWX Technologies, Inc. (BWXT) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $860.2M, roughly 1.6× BWX Technologies, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.6% vs 3.4%, a 7.2% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (26.1% vs 1.3%). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (12.4% CAGR vs 4.9%).

BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

BWXT vs OPCH — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.6× larger
OPCH
$1.4B
$860.2M
BWXT
Growing faster (revenue YoY)
BWXT
BWXT
+24.8% gap
BWXT
26.1%
1.3%
OPCH
Higher net margin
BWXT
BWXT
7.2% more per $
BWXT
10.6%
3.4%
OPCH
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
12.4%
4.9%
OPCH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BWXT
BWXT
OPCH
OPCH
Revenue
$860.2M
$1.4B
Net Profit
$91.2M
$45.3M
Gross Margin
19.4%
Operating Margin
12.4%
5.4%
Net Margin
10.6%
3.4%
Revenue YoY
26.1%
1.3%
Net Profit YoY
20.7%
-3.0%
EPS (diluted)
$0.99
$0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWXT
BWXT
OPCH
OPCH
Q1 26
$860.2M
$1.4B
Q4 25
$885.8M
$1.5B
Q3 25
$866.3M
$1.4B
Q2 25
$764.0M
$1.4B
Q1 25
$682.3M
$1.3B
Q4 24
$746.3M
$1.3B
Q3 24
$672.0M
$1.3B
Q2 24
$681.5M
$1.2B
Net Profit
BWXT
BWXT
OPCH
OPCH
Q1 26
$91.2M
$45.3M
Q4 25
$93.0M
$58.5M
Q3 25
$82.1M
$51.8M
Q2 25
$78.4M
$50.5M
Q1 25
$75.5M
$46.7M
Q4 24
$71.0M
$60.1M
Q3 24
$69.5M
$53.9M
Q2 24
$73.0M
$53.0M
Gross Margin
BWXT
BWXT
OPCH
OPCH
Q1 26
19.4%
Q4 25
19.3%
Q3 25
21.8%
19.0%
Q2 25
25.1%
19.0%
Q1 25
24.2%
19.7%
Q4 24
21.3%
Q3 24
24.4%
20.1%
Q2 24
24.7%
20.3%
Operating Margin
BWXT
BWXT
OPCH
OPCH
Q1 26
12.4%
5.4%
Q4 25
10.4%
6.2%
Q3 25
13.1%
5.9%
Q2 25
13.4%
5.8%
Q1 25
14.2%
5.9%
Q4 24
12.4%
6.9%
Q3 24
14.4%
6.7%
Q2 24
14.5%
6.6%
Net Margin
BWXT
BWXT
OPCH
OPCH
Q1 26
10.6%
3.4%
Q4 25
10.5%
4.0%
Q3 25
9.5%
3.6%
Q2 25
10.3%
3.6%
Q1 25
11.1%
3.5%
Q4 24
9.5%
4.8%
Q3 24
10.3%
4.2%
Q2 24
10.7%
4.3%
EPS (diluted)
BWXT
BWXT
OPCH
OPCH
Q1 26
$0.99
$0.29
Q4 25
$1.02
$0.37
Q3 25
$0.89
$0.32
Q2 25
$0.85
$0.31
Q1 25
$0.82
$0.28
Q4 24
$0.77
$0.36
Q3 24
$0.76
$0.31
Q2 24
$0.79
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWXT
BWXT
OPCH
OPCH
Cash + ST InvestmentsLiquidity on hand
$512.4M
$177.3M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$1.3B
Total Assets
$4.3B
$3.4B
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWXT
BWXT
OPCH
OPCH
Q1 26
$512.4M
$177.3M
Q4 25
$499.8M
$232.6M
Q3 25
$79.6M
$309.8M
Q2 25
$37.0M
$198.8M
Q1 25
$55.4M
$171.4M
Q4 24
$74.1M
$412.6M
Q3 24
$35.5M
$483.0M
Q2 24
$48.3M
$376.9M
Total Debt
BWXT
BWXT
OPCH
OPCH
Q1 26
$2.0B
Q4 25
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
BWXT
BWXT
OPCH
OPCH
Q1 26
$1.3B
Q4 25
$1.2B
$1.3B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.4B
Q1 25
$1.1B
$1.4B
Q4 24
$1.1B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$998.5M
$1.4B
Total Assets
BWXT
BWXT
OPCH
OPCH
Q1 26
$4.3B
$3.4B
Q4 25
$4.3B
$3.5B
Q3 25
$3.8B
$3.5B
Q2 25
$3.7B
$3.4B
Q1 25
$3.1B
$3.3B
Q4 24
$2.9B
$3.4B
Q3 24
$2.9B
$3.4B
Q2 24
$2.8B
$3.3B
Debt / Equity
BWXT
BWXT
OPCH
OPCH
Q1 26
1.58×
Q4 25
Q3 25
0.86×
Q2 25
0.82×
Q1 25
0.82×
Q4 24
0.79×
Q3 24
0.78×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWXT
BWXT
OPCH
OPCH
Operating Cash FlowLast quarter
$92.6M
Free Cash FlowOCF − Capex
$50.1M
FCF MarginFCF / Revenue
5.8%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
1.02×
TTM Free Cash FlowTrailing 4 quarters
$328.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWXT
BWXT
OPCH
OPCH
Q1 26
$92.6M
Q4 25
$127.0M
$258.4M
Q3 25
$143.2M
$139.4M
Q2 25
$159.0M
$90.3M
Q1 25
$50.6M
$-7.2M
Q4 24
$276.9M
$36.1M
Q3 24
$32.6M
$160.4M
Q2 24
$65.9M
$195.7M
Free Cash Flow
BWXT
BWXT
OPCH
OPCH
Q1 26
$50.1M
Q4 25
$56.8M
Q3 25
$94.9M
$130.2M
Q2 25
$126.3M
$81.2M
Q1 25
$17.3M
$-16.6M
Q4 24
$224.4M
$25.8M
Q3 24
$-7.7M
$150.7M
Q2 24
$35.5M
$185.9M
FCF Margin
BWXT
BWXT
OPCH
OPCH
Q1 26
5.8%
Q4 25
6.4%
Q3 25
11.0%
9.1%
Q2 25
16.5%
5.7%
Q1 25
2.5%
-1.2%
Q4 24
30.1%
2.0%
Q3 24
-1.1%
11.8%
Q2 24
5.2%
15.1%
Capex Intensity
BWXT
BWXT
OPCH
OPCH
Q1 26
4.9%
Q4 25
7.9%
Q3 25
5.6%
0.6%
Q2 25
4.3%
0.6%
Q1 25
4.9%
0.7%
Q4 24
7.0%
0.8%
Q3 24
6.0%
0.8%
Q2 24
4.5%
0.8%
Cash Conversion
BWXT
BWXT
OPCH
OPCH
Q1 26
1.02×
Q4 25
1.37×
4.42×
Q3 25
1.74×
2.69×
Q2 25
2.03×
1.79×
Q1 25
0.67×
-0.15×
Q4 24
3.90×
0.60×
Q3 24
0.47×
2.98×
Q2 24
0.90×
3.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons